You are here
Scheduling delegate's final decisions: NCEs, April 2016
Print version
Scheduling of medicines and poisons
28 April 2016
Summary
Final decisions on matters not referred to an expert advisory committee
1. New Chemical Entities - medicines for human therapeutic use
Summary of delegate's final decisions
Schedule 4 - New Entries
- SELEXIPAG
- VORAPAXAR
- ALIROCUMAB
- ELBASVIR
- GRAZOPREVIR
- IDARUCIZUMAB
- HEXYL AMINOLEVULINATE (AS HYDROCHLORIDE)
Implementation date: 1 June 2016